Jane Street Group, LLC Celldex Therapeutics, Inc. Call Options Transaction History

Jane Street Group, LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$32.06 - $44.56 $4.35 Million - $6.05 Million	135,800 New	135,800 $4.61 Million
Q1 2022 May 17, 2022	SELL	$27.64 - $39.32 $77,392 - $110,096	-2,800 Reduced 3.61%	74,800 $2.55 Million
Q4 2021 Feb 15, 2022	BUY	$35.68 - $56.27 $838,480 - $1.32 Million	23,500 Added 43.44%	77,600 $3 Million
Q3 2021 Nov 16, 2021	BUY	$28.95 - $55.99 $1.09 Million - $2.11 Million	37,600 Added 227.88%	54,100 $2.92 Million
Q2 2021 Aug 16, 2021	SELL	$20.71 - $35.37 $111,834 - $190,998	-5,400 Reduced 24.66%	16,500 $552,000
Q1 2021 May 18, 2021	SELL	$16.19 - $29.91 $424,178 - $783,642	-26,200 Reduced 54.47%	21,900 $451,000
Q4 2020 Feb 17, 2021	BUY	$14.99 - $22.75 $59,960 - $91,000	4,000 Added 9.07%	48,100 $843,000
Q3 2020 Nov 17, 2020	BUY	$9.65 - $15.19 $108,080 - $170,128	11,200 Added 34.04%	44,100 $654,000
Q2 2020 Aug 17, 2020	BUY	$1.61 - $13.41 $52,969 - $441,189	32,900 New	32,900 $428,000

207

67.3M

1.69M

980K

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.23B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.